Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Other Working Capital Changes of -$103000.0 for Q1 2026, down 432.26% year-over-year from $31000.0 in Q1 2025, and down 39.19% quarter-over-quarter from -$74000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$103000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 432.26% year-over-year to -$103000.0; the TTM figure through Mar 2026 stood at -$319000.0 (down 382.3% YoY), while the FY2025 annual figure was -$185000.0, up 26.59% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$103000.0, down from -$74000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.3 million in Q3 2025, with the low at -$1.2 million in Q1 2025.
- The 5-year median for Other Working Capital Changes is $87000.0 (2025), against an average of $120823.5.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes jumped 109.28% in 2025, then sank 432.26% in 2026.
- Corvus Pharmaceuticals' Other Working Capital Changes stood at $768000.0 in 2024, then tumbled by 109.64% to -$74000.0 in 2025, then tumbled by 39.19% to -$103000.0 in 2026.
- Business Quant data shows CRVS's Other Working Capital Changes at -$103000.0 in Q1 2026, -$74000.0 in Q4 2025, and -$72000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.25 Bn | 1.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.54 Mn |
| Jun 30, 2026 | 2.54 Mn |
| Jun 30, 2026 | 2.54 Mn |
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |